NCT01794494

Brief Summary

Severe atherosclerosis in the leg arteries is termed critical limb ischemia (CLI). This condition gives great suffering for the patients in terms of pain, wounds and often developing gangrene. Untreated, the condition has a high risk of amputation. In Sweden, the majority of the patients are investigated and evaluated for treatment. Treatment is carried out either by traditional open bypass surgery or balloon dilatation technology (endovascular treatment). The latter method is still under development, and studies have shown that the treatment has less local and systemic complications than bypass surgery. It is also shown that the method has a limitation in that the treatment effect is less durable. What is the role of minimally invasive technologies should have in the future is unclear, mainly due to its efficiency and cost-effectiveness compared with bypass surgery are not evaluated. In a prospective observational study we intend study the effectiveness, cost-effectiveness and impact on quality of life in patients undergoing treatment for critical CLI with bypass surgery or endovascular treatment in Västra Götaland Region (VGR). All patients over a period of two years, which undergo treatment for CLI with either of the two methods will be included in the study. Patients will be followed up with regard to the clinical efficacy and health-related quality of life after treatment at, respectively one, 12 and 24 and 60 months. Cumulative care costs are calculated and estimates of cost are made. This study aims to increase knowledge about the role of endovascular treatment of CLI shall have in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
190

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 20, 2013

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

6.2 years

First QC Date

February 9, 2013

Last Update Submit

April 18, 2023

Conditions

Keywords

Peripheal arterial diseaseCritical limb ischemiaBypass surgerySubintimal angioplastyHealth related cost

Outcome Measures

Primary Outcomes (1)

  • Amputation-free survival

    Freedom of death and amputation during the study

    2 years

Secondary Outcomes (1)

  • Change in Rutherford scale

    2 Years

Other Outcomes (4)

  • Rate of re-intervention

    2 years

  • Health related quality of life

    2 years

  • Health related quality of life

    2 years

  • +1 more other outcomes

Study Arms (2)

Open surgical group

Bypass surgery for critical limb ischemia

Procedure: Bypass surgery

Endovascular treatment

Endovascular recanalization for critical limb ischemia

Procedure: Endovascular recanalization

Interventions

Patients are treated with femoro-popliteal bypass

Open surgical group

Patients are treated with PTA or subintimal angioplasty

Endovascular treatment

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with critical limb ischemia coming to the for vascular department in the western region of Sweden.

You may qualify if:

  • patients with CLI due to arterial occlusion of the superficial femoral artery and/or the popliteal artery being considered for bypass surgery or SAP at any of the four vascular surgical units in VGR.

You may not qualify if:

  • patients with CLI due to arterial occlusion of the aorto-iliac arterial segment or distal to the politeal segment.
  • Patients with inability to understand patientinformation and informed concens.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of vascular surgery, Sahlgrenska University Hospital

Gothenborg, 413 45, Sweden

Location

Related Publications (10)

  • 1.Benartärsjukdom diagnostics and treatment. A systematic literature review. 2007: SBU. Swedish Council on Technology Assessment.

    BACKGROUND
  • Barani J, Mattiasson I, Lindblad B, Gottsater A. Suboptimal treatment of risk factor for atherosclerosis in critical limb ischemia. Int Angiol. 2005 Mar;24(1):59-63.

    PMID: 15877000BACKGROUND
  • Met R, Van Lienden KP, Koelemay MJ, Bipat S, Legemate DA, Reekers JA. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):687-97. doi: 10.1007/s00270-008-9331-7. Epub 2008 Apr 15.

    PMID: 18414946BACKGROUND
  • Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 Dec 3;366(9501):1925-34. doi: 10.1016/S0140-6736(05)67704-5.

    PMID: 16325694BACKGROUND
  • KUNLIN J. [Long vein transplantation in treatment of ischemia caused by arteritis]. Rev Chir. 1951 Jul-Aug;70(7-8):206-35. No abstract available. Undetermined Language.

    PMID: 14865345BACKGROUND
  • Bolia A, Miles KA, Brennan J, Bell PR. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol. 1990 Dec;13(6):357-63. doi: 10.1007/BF02578675.

    PMID: 2149672BACKGROUND
  • Diehm N, Pattynama PM, Jaff MR, Cremonesi A, Becker GJ, Hopkins LN, Mahler F, Talen A, Cardella JF, Ramee S, van Sambeek M, Vermassen F, Biamino G. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg. 2008 Oct;36(4):409-19. doi: 10.1016/j.ejvs.2008.06.020. Epub 2008 Aug 8.

    PMID: 18692415BACKGROUND
  • Bjoholt I, Janson M, Jonsson B, Haglind E. Principles for the design of the economic evaluation of COLOR II: an international clinical trial in surgery comparing laparoscopic and open surgery in rectal cancer. Int J Technol Assess Health Care. 2006 Winter;22(1):130-5. doi: 10.1017/s0266462306050926.

    PMID: 16673689BACKGROUND
  • Sullivan M, KJTC, SF-36 Health Survey: Manual and Interpretation Swedish Guide, Second Edition, Göteborg: Sahlgrenska University Hospital

    BACKGROUND
  • Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg. 2001 Apr;33(4):679-87. doi: 10.1067/mva.2001.112326.

    PMID: 11296317BACKGROUND

MeSH Terms

Conditions

Chronic Limb-Threatening Ischemia

Interventions

Coronary Artery Bypass

Condition Hierarchy (Ancestors)

Peripheral Arterial DiseaseAtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsIschemia

Intervention Hierarchy (Ancestors)

Myocardial RevascularizationCardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeVascular GraftingVascular Surgical ProceduresThoracic Surgical Procedures

Study Officials

  • Klas Österberg, MD, PhD

    Sahlgrenska University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

February 9, 2013

First Posted

February 20, 2013

Study Start

November 1, 2011

Primary Completion

January 1, 2018

Study Completion

January 1, 2019

Last Updated

April 21, 2023

Record last verified: 2023-04

Locations